The second complex of mTOR, namely mTORC2, has been demonstrated as playing an important role in the promotion of cancer cell survival, proliferation, growth, and motility based on its ability to enhance the phosphorylation of AktSer473, the key regulator of the insulin/PI3K pathway [9,223]. This evidence concerns the gene MTOR and cancer.